Camrelizumab Helpful Addition to Breast Cancer Treatment

Participants in a trial were randomized to receive either 200 mg camrelizumab or placebo combined with chemotherapy every 2 weeks for 14 months.
Medscape Medical News

source https://www.medscape.com/viewarticle/camrelizumab-plus-chemotherapy-boosts-response-triple-2024a1000n9x?src=rss